Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth.


Journal

Cellular and molecular biology (Noisy-le-Grand, France)
ISSN: 1165-158X
Titre abrégé: Cell Mol Biol (Noisy-le-grand)
Pays: France
ID NLM: 9216789

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 24 10 2022
medline: 14 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are the most common motoneuron diseases affecting adults and infants, respectively. ALS and SMA are both characterized by the selective degeneration of motoneurons. Although different in their genetic etiology, growing evidence indicates that they share molecular and cellular pathogenic signatures that constitute potential common therapeutic targets. We previously described a motoneuron-specific death pathway elicited by the Fas death receptor, whereby vulnerable ALS motoneurons show an exacerbated sensitivity to Fas activation. However, the mechanisms that drive the loss of SMA motoneurons remains poorly understood. Here, we describe an in vitro model of SMA-associated degeneration using primary motoneurons derived from Smn2B/- SMA mice and show that Fas activation selectively triggers death of the proximal motoneurons. Fas-induced death of SMA motoneurons has the molecular signature of the motoneuron-selective Fas death pathway that requires activation of p38 kinase, caspase-8, -9 and -3 as well as upregulation of collapsin response mediator protein 4 (CRMP4). In addition, Rho-associated Kinase (ROCK) is required for Fas recruitment. Remarkably, we found that exogenous activation of Fas also promotes axonal elongation in both wildtype and SMA motoneurons. Axon outgrowth of motoneurons promoted by Fas requires the activity of ERK, ROCK and caspases. This work defines a dual role of Fas signaling in motoneurons that can elicit distinct responses from cell death to axonal growth.

Identifiants

pubmed: 37953591
doi: 10.14715/cmb/2023.69.10.1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Salim Benlefki (S)

INM, Univ Montpellier, INSERM, Montpellier, France. salim.benlefki@dbb.su.se.

Richard Younes (R)

INM, Univ Montpellier, INSERM, Montpellier, France. richard.younes@inserm.fr.

Désiré Challuau (D)

INM, Univ Montpellier, INSERM, Montpellier, France. desire.challuau@inserm.fr.

Nathalie Bernard-Marissal (N)

Aix Marseille Univ, Inserm, MMG, U1251, Marseille, France. nathalie.BERNARD.1@univ-amu.fr.

Cécile Hilaire (C)

INM, Univ Montpellier, INSERM, Montpellier, France. cecile.hilaire@inserm.fr.

Frédérique Scamps (F)

INM, Univ Montpellier, INSERM, Montpellier, France. frederique.scamps@inserm.fr.

Melissa Bowerman (M)

School of Medicine, Keele University, Staffordshire, United Kingdom. m.bowerman@keele.ac.uk.

Rashmi Kothary (R)

Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. rkothary@ohri.ca.

Bernard L Schneider (BL)

Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. bernard.schneider@epfl.ch.

Cedric Raoul (C)

INM, Univ Montpellier, INSERM, Montpellier, France. cedric.raoul@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH